• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫刺激复合物:一种具有多种功能的佐剂。

ISCOMs: an adjuvant with multiple functions.

作者信息

Sjölander A, Cox J C, Barr I G

机构信息

Immunology Department, CSL Limited, Parkville, Melbourne, Australia.

出版信息

J Leukoc Biol. 1998 Dec;64(6):713-23. doi: 10.1002/jlb.64.6.713.

DOI:10.1002/jlb.64.6.713
PMID:9850152
Abstract

Aluminum salts are currently the only widely used adjuvant for human vaccines. Over the past 10-15 years, a large research effort has attempted to find novel adjuvants with ability to induce a broad range of immune responses, including cell-mediated immunity. The immunostimulating complex or ISCOM is one adjuvant with multiple adjuvant properties. ISCOMs are open cage-like complexes typically with a diameter of about 40 nm that are built up by cholesterol, lipid, immunogen, and saponins from the bark of the tree Quillaia saponaria Molina. ISCOMs have been demonstrated to promote antibody responses and induce T helper cell as well as cytotoxic T lymphocyte responses in a variety of experimental animal models, and have now progressed to phase I and II human trials. This review describes recent developments in the understanding of the structure, composition, and preparation of ISCOMs and will cover important aspects of the understanding of the adjuvant functions of ISCOMs and how they act on the immune system.

摘要

铝盐是目前人类疫苗中唯一广泛使用的佐剂。在过去10到15年里,大量研究致力于寻找能够诱导广泛免疫反应(包括细胞介导免疫)的新型佐剂。免疫刺激复合物(ISCOM)就是一种具有多种佐剂特性的佐剂。ISCOM是一种开放的笼状复合物,直径通常约为40纳米,由胆固醇、脂质、免疫原以及来自皂树(Quillaia saponaria Molina)树皮的皂苷组成。在多种实验动物模型中,ISCOM已被证明能促进抗体反应,诱导辅助性T细胞以及细胞毒性T淋巴细胞反应,目前已进入I期和II期人体试验。本综述描述了对ISCOM结构、组成和制备的理解方面的最新进展,并将涵盖对ISCOM佐剂功能及其作用于免疫系统方式的理解的重要方面。

相似文献

1
ISCOMs: an adjuvant with multiple functions.免疫刺激复合物:一种具有多种功能的佐剂。
J Leukoc Biol. 1998 Dec;64(6):713-23. doi: 10.1002/jlb.64.6.713.
2
Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines.口服皂苷和免疫刺激复合物(ISCOM)疫苗的摄取及佐剂活性
Adv Drug Deliv Rev. 1998 Dec 1;34(2-3):321-338. doi: 10.1016/s0169-409x(98)00046-5.
3
Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.用于免疫刺激复合物(ISCOM)基质的无毒皂树(Quillaja saponaria Molina)成分的佐剂活性。
Vaccine. 1995 Oct;13(14):1375-82. doi: 10.1016/0264-410x(95)00105-a.
4
ISCOM-based vaccines: the second decade.基于免疫刺激复合物(ISCOM)的疫苗:第二个十年
Immunol Cell Biol. 2005 Apr;83(2):119-28. doi: 10.1111/j.1440-1711.2005.01319.x.
5
Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.来自巴西皂树皂苷的新型免疫刺激复合物(ISCOMs)可诱导黏膜和全身抗体产生、T细胞反应并改善抗原摄取。
Vaccine. 2016 Feb 24;34(9):1162-71. doi: 10.1016/j.vaccine.2016.01.029. Epub 2016 Jan 28.
6
ISCOMs (immunostimulating complexes): the first decade.
Immunol Cell Biol. 1996 Feb;74(1):8-25. doi: 10.1038/icb.1996.2.
7
ISCOMs and ISCOMATRIX.免疫刺激复合物及免疫刺激复合物基质
Vaccine. 2009 Jul 16;27(33):4388-401. doi: 10.1016/j.vaccine.2009.05.032. Epub 2009 May 28.
8
Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.皂树皂苷和脂质在免疫刺激复合物基质及免疫刺激复合物中的分离与定量分析
Vaccine. 1995 Dec;13(17):1690-6. doi: 10.1016/0264-410x(95)00107-c.
9
ISCOMs and other saponin based adjuvants.免疫刺激复合物(ISCOMs)及其他基于皂苷的佐剂。
Adv Drug Deliv Rev. 1998 Jul 6;32(3):247-271. doi: 10.1016/s0169-409x(98)00013-1.
10
Current status and potential application of ISCOMs in veterinary medicine.免疫刺激复合物(ISCOMs)在兽医学中的现状与潜在应用
Adv Drug Deliv Rev. 2004 Jun 23;56(10):1367-82. doi: 10.1016/j.addr.2004.02.004.

引用本文的文献

1
Leaf Saponins of as Powerful Vaccine Adjuvants.作为强效疫苗佐剂的[植物名称]叶皂苷
Pharmaceutics. 2025 Jul 25;17(8):966. doi: 10.3390/pharmaceutics17080966.
2
ISCOM-type matrix from beta-escin and glycyrrhizin saponins.来源于七叶皂苷和甘草皂苷的免疫刺激复合物(ISCOM)型基质。
Heliyon. 2025 Jan 13;11(2):e41935. doi: 10.1016/j.heliyon.2025.e41935. eCollection 2025 Jan 30.
3
Local and systemic humoral immune responses to Histophilus somni recombinant antigens administered intranasally and subcutaneously to dairy calves.
鼻内和皮下给予奶牛犊牛Histophilus somni 重组抗原后局部和全身体液免疫应答。
Sci Rep. 2024 Nov 11;14(1):27567. doi: 10.1038/s41598-024-78605-x.
4
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.基于纳米平台的鼻腔内疫苗:当前进展和临床挑战。
ACS Nano. 2024 Sep 10;18(36):24650-24681. doi: 10.1021/acsnano.3c10797. Epub 2024 Aug 26.
5
Advances in Poultry Vaccines: Leveraging Biotechnology for Improving Vaccine Development, Stability, and Delivery.家禽疫苗的进展:利用生物技术改进疫苗研发、稳定性和递送
Vaccines (Basel). 2024 Jan 28;12(2):134. doi: 10.3390/vaccines12020134.
6
Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles.用与海藻酸盐包被的壳聚糖纳米颗粒共同给药的ISCOMATRIX纳米佐剂进行针对结核病的粘膜和全身免疫接种。
Iran J Basic Med Sci. 2023;26(10):1162-1167. doi: 10.22038/IJBMS.2023.67564.14806.
7
ISCOMs/MPLA-Adjuvanted SDAD Protein Nanoparticles Induce Improved Mucosal Immune Responses and Cross-Protection in Mice.ISCOMs/MPLA- 佐剂化 SDAD 蛋白纳米颗粒可诱导小鼠黏膜免疫应答和交叉保护作用增强。
Small. 2023 Aug;19(34):e2301801. doi: 10.1002/smll.202301801. Epub 2023 May 10.
8
Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies.在动物研究中,一种基于刺突蛋白亚单位的 COVID-19 疫苗具有广泛的针对各种 SARS-CoV-2 变体的免疫原性。
PLoS One. 2023 Mar 24;18(3):e0283473. doi: 10.1371/journal.pone.0283473. eCollection 2023.
9
An inventory of adjuvants used for vaccination in horses: the past, the present and the future.用于马接种疫苗的佐剂清单:过去、现在和未来。
Vet Res. 2023 Mar 2;54(1):18. doi: 10.1186/s13567-023-01151-3.
10
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era.皂苷:研究进展及其在新冠疫情后时代的潜在作用
Pharmaceutics. 2023 Jan 20;15(2):348. doi: 10.3390/pharmaceutics15020348.